The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Kansei Engineering Matches Runners’ Own Emotions To Their Shoes
A joint venture between RMIT University and Japan's Mizuno Corporation is applying the emotions of runners to develop the next-generation personalized running shoe.
International Women’s Day 2012: Educate And Empower Girls And Women
On International Women’s Day 2012, UN Rep Margareta Wahlström calls on governments of disaster-prone countries to empower girls and women through education.
CK Life Sciences Receives FDA Clearance For PhIII Melanoma Vaccine Trial
CK Life Sciences subsidiary Polynoma LLC has received FDA clearance for Phase III clinical testing of its melanoma vaccine.
OPINION: Can We Colonize The Moon?
Prof. Leonhard Bernold at the University of New South Wales discusses whether we have the technological know-how to colonize the moon.
Punjab Heart Drug Debacle – A Way Forward For Pakistan
Dr. Sania Nishtar discusses the need for tighter drug regulation in Pakistan after the deaths of 150 people from a faulty cardiovascular drug prescription.
Medicago Inc And Mitsubishi Tanabe Pharma Enter Into Vaccine Alliance
Medicago Inc. has entered into a strategic alliance with Mitsubishi Tanabe Pharma Corporation to develop and commercialize at least three new vaccines together.
Sawfish Wield Their Saws Like A Chainsaw, Study
Australian researchers have recently made a startling discovery – a sawfish’s saw can actually sense electric fields to locate and attack prey.
Millennium Development Goal Drinking Water Target Met
The world has met the Millennium Development Goal target of halving the proportion of people without access to safe drinking water, says UNICEF and WHO.
Millennium Initiates Phase III Trial On Peripheral T-Cell Lymphoma Drug
Millennium today announced the initiation of an international Phase III clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma.